XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.23.1

Variable Interest Entities (VIEs) | 3 Months Ended
--- | ---
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Variable Interest Entities (VIEs) | Variable Interest Entities (VIEs)A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity’s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE. The Company follows guidance on the consolidation of VIEs that requires companies to utilize a qualitative approach to determine whether it is the primary beneficiary of a VIE. See Note 2 — “Basis of Presentation and Summary of Significant Accounting Policies — Variable Interest Entities” to the accompanying consolidated financial statements for information on how the Company determines VIEs and their treatment. The following table includes assets that can only be used to settle the liabilities of APC and its consolidated entities and VIEs, including Alpha Care and Accountable Health Care, and to which the creditors of ApolloMed have no recourse, and liabilities to which the creditors of APC, including Alpha Care and Accountable Health Care, have no recourse to the general credit of ApolloMed, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to affiliates, which are eliminated upon consolidation with NMM, are included in the accompanying consolidated balance sheets (in thousands). The assets and liabilities of the Company’s other consolidated VIEs were not considered significant.
| March 31, 2023 |  | December 31, 2022
Assets |  |  |
Current assets |  |  |
Cash and cash equivalents | $ | 96,018 |  |  | $ | 97,669 |
Investment in marketable securities | 1,538 |  |  | 4,543 |
Receivables, net | 14,369 |  |  | 11,503 |
Receivables, net – related party | 70,565 |  |  | 62,190 |
Other receivables | 1,268 |  |  | 1,236 |
Prepaid expenses and other current assets | 18,241 |  |  | 9,289 |
Loan receivable | — |  |  | 22 |
Loan receivable – related party | — |  |  | 2,125 |
Amount due from affiliates* | 33,979 |  |  | 30,340 |
Total current assets | 235,978 |  |  | 218,917 |
Non-current assets |  |  |
Land, property, and equipment, net | 110,829 |  |  | 106,486 |
Intangible assets, net | 51,667 |  |  | 53,964 |
Goodwill | 116,804 |  |  | 118,161 |
Investment in affiliates* | 375,614 |  |  | 304,755 |
Investments in other entities – equity method | 29,758 |  |  | 27,561 |
Investment in privately held entities | 405 |  |  | 405 |
Operating lease right-of-use assets | 4,961 |  |  | 6,503 |
Other assets | 3,513 |  |  | 4,169 |
Total non-current assets | 693,551 |  |  | 622,004 |
Total assets | $ | 929,529 |  |  | $ | 840,921 |
Current liabilities |  |  |
Accounts payable and accrued expenses | $ | 22,823 |  |  | $ | 23,632 |
Fiduciary accounts payable | 8,923 |  |  | 7,853 |
Medical liabilities | 43,948 |  |  | 48,100 |
Income taxes payable | 8,065 |  |  | 1,083 |
Dividends payable | 638 |  |  | 638 |
Current portion of long-term debt | 621 |  |  | 619 |
Finance lease liabilities | 579 |  |  | 594 |
Operating lease liabilities | 1,489 |  |  | 1,800 |
| March 31, 2023 |  | December 31, 2022
Total current liabilities | 87,086 |  |  | 84,319 |
Non-current liabilities |  |  |
Long-term debt, net of current portion and deferred financing costs | 27,965 |  |  | 26,645 |
Deferred tax liability | 813 |  |  | 1,465 |
Finance lease liabilities, net of current portion | 1,136 |  |  | 1,275 |
Operating lease liabilities, net of current portion | 6,136 |  |  | 7,484 |
Other long-term liabilities | 8,686 |  |  | 8,542 |
Total non-current liabilities | 44,736 |  |  | 45,411 |
Total liabilities | $ | 131,822 |  |  | $ | 129,730 |
*Investment in affiliates includes APC’s investment in ApolloMed, which is reflected as treasury shares and eliminated upon consolidation. Amount due from affiliates are receivables with ApolloMed’s subsidiaries and consolidated VIEs. As a result, these balances are eliminated upon consolidation and are not reflected on ApolloMed’s consolidated balance sheets as of March 31, 2023 and December 31, 2022.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -URI https://asc.fasb.org/topic&trid=2197479 + Details
Name: | us-gaap_VariableInterestEntityDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration